Ubs Group Ag Amgen Inc Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

30 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $10.6 Million - $11.5 Million	34,196 Added 29.61%	149,700 $48.2 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $10.1 Million - $12.3 Million	38,504 Added 50.01%	115,504 $36.1 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $61.4 Million - $74.1 Million	-228,435 Reduced 74.79%	77,000 $21.9 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $40.4 Million - $45.6 Million	157,935 Added 107.07%	305,435 $88 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $2.01 Million - $2.5 Million	-9,200 Reduced 5.87%	147,500 $39.6 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $4.46 Million - $5.27 Million	20,800 Added 15.31%	156,700 $34.8 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $6.48 Million - $7.9 Million	-28,700 Reduced 17.44%	135,900 $32.9 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $12.2 Million - $15.5 Million	53,300 Added 47.89%	164,600 $43.2 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $3.66 Million - $4.13 Million	16,300 Added 17.16%	111,300 $25.1 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $3.46 Million - $3.85 Million	15,000 Added 18.75%	95,000 $23.1 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $14 Million - $15.5 Million	64,000 Added 400.0%	80,000 $19.3 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $5.23 Million - $5.99 Million	-26,321 Reduced 62.19%	16,000 $3.6 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $2.33 Million - $2.73 Million	-10,979 Reduced 20.6%	42,321 $9 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1.68 Million - $1.87 Million	-7,200 Reduced 11.9%	53,300 $13 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $1.66 Million - $1.94 Million	7,500 Added 14.15%	60,500 $15.1 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $1.71 Million - $2.04 Million	7,900 Added 17.52%	53,000 $12.2 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $6.73 Million - $7.49 Million	28,700 Added 175.0%	45,100 $11.5 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $6.41 Million - $7.86 Million	-32,400 Reduced 66.39%	16,400 $3.87 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $5.94 Million - $7.88 Million	-32,600 Reduced 40.05%	48,800 $9.89 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $14.2 Million - $18.2 Million	74,900 Added 1152.31%	81,400 $19.6 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $100,020 - $117,246	-600 Reduced 8.45%	6,500 $1.2 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $289,392 - $326,208	-1,600 Reduced 18.39%	7,100 $1.35 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $4.34 Million - $5.06 Million	-24,300 Reduced 73.64%	8,700 $1.69 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $92,645 - $104,445	-500 Reduced 1.49%	33,000 $6.84 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $4.3 Million - $4.83 Million	25,900 Added 340.79%	33,500 $6.18 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $3.96 Million - $4.63 Million	-23,400 Reduced 75.48%	7,600 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $2.55 Million - $2.85 Million	15,100 Added 94.97%	31,000 $5.39 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $184,019 - $210,100	1,100 Added 7.43%	15,900 $2.97 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-10,200 Reduced 40.8%	14,800 $2.55 Million
Q1 2017 Nov 14, 2017	BUY	N/A	25,000	25,000 $4.1 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account